INNOVATIVE EYEWEAR, INC. Selling and Marketing Expense
INNOVATIVE EYEWEAR, INC. (LUCY) reported Selling and Marketing Expense of $551.81 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for the quarter ending 2026-06-30 was $551.81K, a 1.38% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for the quarter ending 2026-03-31 was $784.05K, a 0.43% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for the quarter ending 2025-12-31 was $916.10K, a 14.34% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for the quarter ending 2025-09-30 was $723.37K, a 35.70% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for fiscal 2025 was $2.97M, a 9.79% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for fiscal 2024 was $2.71M, a 32.20% increase from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for fiscal 2023 was $2.05M, a 0.58% decline from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. selling and marketing expense for fiscal 2022 was $2.06M, a 16.26% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $551.81K 10-Q · filed 2026-08-14 | $1.34M 10-Q · filed 2026-08-14 | $2.25M derived: sum of 3 quarters · filed 2026-08-14 | $2.98M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $784.05K 10-Q · filed 2026-05-14 | $1.70M derived: sum of 2 quarters · filed 2026-05-14 | $2.42M derived: sum of 3 quarters · filed 2026-05-14 | $2.97M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $916.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.64M derived: sum of 2 quarters · filed 2026-03-25 | $2.18M derived: sum of 3 quarters · filed 2026-08-14 | $2.97M 10-K · filed 2026-03-25 |
| 2025-09-30 | $723.37K 10-Q · filed 2025-11-13 | $1.27M derived: sum of 2 quarters · filed 2026-08-14 | $2.06M 10-Q · filed 2025-11-13 | $3.12M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $544.32K 10-Q · filed 2026-08-14 | $1.33M 10-Q · filed 2026-08-14 | $2.40M derived: sum of 3 quarters · filed 2026-08-14 | $2.93M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $787.40K 10-Q · filed 2026-05-14 | $1.86M derived: sum of 2 quarters · filed 2026-05-14 | $2.39M derived: sum of 3 quarters · filed 2026-05-14 | $2.83M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.60M derived: sum of 2 quarters · filed 2026-03-25 | $2.04M derived: sum of 3 quarters · filed 2026-03-25 | $2.71M 10-K · filed 2026-03-25 |
| 2024-09-30 | $533.07K 10-Q · filed 2025-11-13 | $975.50K derived: sum of 2 quarters · filed 2025-11-13 | $1.64M 10-Q · filed 2025-11-13 | $2.79M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $442.43K 10-Q · filed 2025-08-14 | $1.10M 10-Q · filed 2025-08-14 | $2.25M derived: sum of 3 quarters · filed 2025-08-14 | $2.79M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $661.29K 10-Q · filed 2025-05-13 | $1.81M derived: sum of 2 quarters · filed 2025-05-13 | $2.35M derived: sum of 3 quarters · filed 2025-05-13 | $2.45M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.68M derived: sum of 2 quarters · filed 2025-03-24 | $1.79M derived: sum of 3 quarters · filed 2025-03-24 | $2.05M 10-K · filed 2025-03-24 |
| 2023-09-30 | $533.90K 10-Q · filed 2024-11-12 | $637.54K derived: sum of 2 quarters · filed 2024-11-12 | $896.84K 10-Q · filed 2024-11-12 | $1.41M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $103.64K 10-Q · filed 2024-08-12 | $362.94K 10-Q · filed 2024-08-12 | $876.34K derived: sum of 3 quarters · filed 2024-08-12 | $1.45M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $259.30K 10-Q · filed 2024-05-14 | $772.69K derived: sum of 2 quarters · filed 2024-05-14 | $1.34M derived: sum of 3 quarters · filed 2024-05-14 | $1.73M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $513.40K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.08M derived: sum of 2 quarters · filed 2024-03-25 | $1.47M derived: sum of 3 quarters · filed 2024-03-25 | $2.06M 10-K · filed 2024-03-25 |
| 2022-09-30 | $568.90K 10-Q · filed 2023-11-14 | $960.82K derived: sum of 2 quarters · filed 2023-11-14 | $1.55M 10-Q · filed 2023-11-14 | $2.41M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $391.92K 10-Q · filed 2023-08-11 | $976.71K 10-Q · filed 2023-08-11 | $1.84M derived: sum of 3 quarters · filed 2023-08-11 | $2.36M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $584.80K 10-Q · filed 2023-05-12 | $1.45M derived: sum of 2 quarters · filed 2023-05-12 | $1.96M derived: sum of 3 quarters · filed 2023-05-12 | $2.24M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $867.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.38M derived: sum of 2 quarters · filed 2023-03-24 | $1.65M derived: sum of 3 quarters · filed 2023-03-24 | $1.77M 10-K · filed 2023-03-24 |
| 2021-09-30 | $512.94K 10-Q · filed 2022-11-10 | $783.75K derived: sum of 2 quarters · filed 2022-11-10 | $903.79K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $270.81K 10-Q · filed 2022-09-26 | $390.86K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |